1718P A French experience on COVID-19 and cancer from an academic general hospital in Paris area

Abstract

Cancer is considered as a crucial risk factor for adverse outcomes from coronavirus disease 2019 (COVID-19). There is currently few data available about the impact of the virus on patients (pts) treated for cancer, mainly coming from Comprehensive Cancer Centres. In April 2020, the Italian Medical Council reported an analysis on 909 pts who died from COVID-19, of whom 16.5% had cancer. Recently, Gustave Roussy Institute in Paris published a series of 137 cancer patients presenting COVID-19. Here, we report our experience in Foch Hospital in Paris, an academic general hospital located in one of the two main epicentres of the epidemic in France.